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Abstract
Background: Lifestyle behaviors have been widely reported to influence the survival of patients with head and neck cancer.
However, the relationship between pretreatment lifestyle behaviors and survival among patients with nasopharyngeal
carcinoma (NPC) is unclear.
Methods: A prospective cohort study was designed to determine the relationship between lifestyle behaviors and survival
in 1,533 NPC patients recruited from October 2005 to October 2007. Pretreatment lifestyle behaviors (such as body-mass
index [BMI], smoking, alcohol, diet) of the patients were investigated. Univariate and multivariate proportional-hazards
models were used to assess the impact of lifestyle behaviors on patient survival.
Results: Smoking was a predictor of survival; both current smokers (hazard ratio [HR]=1.88; 95% CI, 1.33 to 2.65) and heavy
smokers ($25 Pack-years; HR=1.84; 95% CI, 1.30 to 2.60) showed associations with poor survival. Higher BMI was
significantly associated with a lower risk of death (Ptrend=0.002). Compared with under/normal-weight patients (BMI less
than 22.99 kg/m
2), the multivariate HR for survival was 0.66 (95% CI, 0.48 to 0.90) and 0.47 (95% CI, 0.23 to 0.97) for
overweight and obese patients, respectively. No alcohol intake and high fruit intake were associated with favorable survival
in the univariate analysis but lost significance in the multivariate model.
Conclusion: Our findings indicate that pretreatment lifestyle behaviors, especially smoking status and BMI, as easily
available data, provide prognostic value for survival in NPC patients.
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Introduction
Lifestyle behaviors are reported to influence clinical outcomes
for patients with head and neck cancer [1–3]. In a multicenter
study, cigarette smoking and high levels of alcohol consumption
were found to adversely affect the survival of patients with
laryngeal and hypopharyngeal cancers, whereas high intakes of
vegetables and poultry had favorable effects on prognosis [2].
Another prospective cohort study found that pretreatment health
behaviors (e.g., smoking, fruit intake, and physical activity)
predicted survival among patients with head and neck squamous
cell carcinoma [3].
Nasopharyngeal carcinoma (NPC) is a unique and endemic
head and neck epithelial malignancy that occurs predominantly in
southern China. Epstein Barr virus (EBV) being a primary cause of
NPC plays an important role on the etiology [4]. Lifestyle
behaviors such as smoking tobacco, consuming alcohol, eating
salted-fish and other dietary habits have been linked to the
development of NPC [5–7]. However, whether lifestyle behaviors
are associated with the survival of patients with NPC is unclear.
In previous research, we conducted an epidemiological inves-
tigation to evaluate lifestyle and other environmental factors
influencing NPC risk. In that study, our team profiled the lifestyle
behaviors of newly identified NPC patients at diagnosis. Simul-
taneously, we launched a prospective cohort study to assess the
association between lifestyle behaviors and survival in NPC
patients. Now, after longer follow-up, the present study was
undertaken to determine whether lifestyle behaviors (including
body-mass index [BMI], smoking, alcohol use, dietary factors, tea
consumption, and a Cantonese herbal tea habit) predict survival
among patients with NPC.
If pretreatment lifestyle behaviors are predictive of survival
among patients with NPC, the information would be useful for
developing clinical and public health interventions to improve
survival. The lifestyle behaviors questionnaire may become a
practical and non-invasive means of identifying those patients at
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36515high risk who require tailored medical support before treatment
and those who must be observed more closely after treatment.
Moreover, lifestyle behaviors not only associated with increased
risk for certain cancers and survival period, but also with enhanced
risk of chronic diseases such as diabetes, stroke, and coronary heart
disease, all of which influence on people’s life length severely [8,9].
From the point of view, investigation on lifestyle behaviors could
be great meaningful price for public health.
Results
The demographic characteristics of the patients, their lifestyle
behaviors, and their clinical information are all summarized in
Table 1. At the time of diagnosis, the mean patient age was 46.1
years (SD=11.1 years). Most patients were living with their spouse
(94.7%). Four-hundred-ten patients (26.7%) were female and 234
patients (15.3%) had higher education. Approximately one-half
smoked, one-third drank regularly, and almost one-quarter
consumed fruit less than once per month. The mean BMI was
22.6 kg/m2 (SD=3.2 kg/m
2). one hundred and forty-one pa-
tients (9.2%) were underweight, 733 patients (47.8%) were normal-
weight, 552 patients (36%) were overweight and 107 patients (7%)
were obese. After a median follow-up of 3.3 years, 243 deaths
(15.9%) were observed among the 1,533 participants. The 3-year
survival rate was 86.8% (95% CI, 85.0%–88.5%).
Univariate Cox Proportional Hazards Regression Analysis
Clinical variables found to be associated (P,0.05) with survival
in the univariate Cox proportional hazards regression analyses
included age (1-year increment, P=0.004), sex (female vs. male,
P,0.0001), clinical stage (P,0.0001), and treatment (concurrent
chemoradiotherapy versus radiotherapy plus induction and/or
adjuvant chemotherapy, P,0.0001). Among the two demographic
characteristics (marital status and education), being without a
spouse was not associated with survival in univariate analysis. A
favorable survival was found to be associated with higher
education (P=0.008) (table 2).
The univariate analysis showed that four lifestyle behaviors
(smoking status, alcohol intake, fruit intake, and BMI) were
significantly associated with survival (Fig. 1). The pretreatment
smoker, whether current or former smoker, were strongly
associated with poor survival. A pack-years dosage effect on
survival was observed when pack-years were divided into light
smokers (,25 pack-years; HR=1.85; 95% CI, 1.34 to 2.54) and
heavy smokers ($25 pack-years; HR=2.46; 95% CI, 1.80 to 3.37)
Table 1. Patient characteristics.
Variable No (n=1533) %
Age, years
Mean 46.1
SD 11.1
#30 108 7.1
31–40 385 25.1
41–50 512 33.4
51–60 367 23.9
$61 161 10.5
Sex
Male 1123 73.3
Female 410 26.7
Marital status
With spouse 1451 94.7
Without spouse 82 5.3
Educational level
High school or less 1299 84.7
University or more 234 15.3
Body mass index, kg/m
2
Mean 22.6
SD 3.2
Underweight (less than 18.5) 141 9.2
Normal weight (18.5 to 22.99) 733 47.8
Overweight (23.0 to 27.49) 552 36.0
Obesity (27.5 or more) 107 7.0
Smoking status
Current 436 28.4
Former 395 25.8
Never 702 45.8
Pack-years
Never 712 46.4
,25 Pack-years 437 28.5
$25 Pack-years 384 25.0
Alcohol intake
Nondrinker 912 59.5
#1 drink per day 533 34.8
.1 drink per day 88 5.7
Duration of alcohol intake
Nondrinker 912 59.5
,20 years 533 34.8
$20 years 88 5.7
Fruits
Less than monthly 353 23.0
Monthly,weekly 645 42.1
Daily or more 535 34.9
Clinical stage
I 106 6.9
II 350 22.8
III 614 40.1
Table 1. Cont.
Variable No (n=1533) %
IV 463 30.2
Pathology
WHO I 19 1.2
WHO II 132 8.6
WHO III 1382 90.2
Treatment
Radiotherapy alone 440 28.7
Radiotherapy+chemotherapy 456 29.7
Concurrent chemoradiotherapy 637 41.6
doi:10.1371/journal.pone.0036515.t001
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intake was also associated with poor survival. A strong adverse
effect on survival was observed with an average of more than 1
drink per day, with a hazard ratio of 2.22 (95% CI, 1.41% to
3.50%, P=0.001). A drinking duration of 20 years or more was
also associated with unfavorable survival (P=0.019). High
frequency intake of fruit significantly improved the survival. Daily
consumption of fruit was associated with 37% (95% CI, 11% to
54%) reduction in the likelihood of death. Being overweight or
obese was positively associated with survival. The risk of death was
0.62 (95% CI, 0.46 to 0.85) and 0.44 (95% CI, 0.22 to 0.90) for
overweight and obese individuals, respectively, compared with
those of normal weight. The results of the univariate Cox
proportional hazards regression models are listed in Table 2.
However, we did not find that consumption of Cantonese herbal
tea or tea was associated with survival (Table S1).
Multivariate Cox Proportional Hazards Regression
Analysis
We developed a multivariate model to adjust the association
between lifestyle behaviors and survival (table 3). Considering the
multicollinearity among lifestyle behavior variables, the variables
in multivariate model included age, marital status, education,
clinical stage (3 levels), smoking (current, former, and never),
alcohol drink (.1/day vs. ,1/day), fruits (3 levels), and BMI (3
levels). The correlation coefficients of the association between each
variable were all not greater than 0.3. The multivariate model was
not included the variable of sex because the coefficient of
correlation between sex and smoking status was 0.59 (.0.30).
Treatment was also not included as a covariate in model because
the patients were generally treated with guideline base on their
cancer stage and treatment was inextricably associated with tumor
stage and the coefficient of correlation between treatment and
clinical stage was 0.39 (.0.30). Of the lifestyle behaviors, smoking
status and BMI remained statistically significant. The pretreat-
ment current smoker variable was associated with poor survival.
The risk of death was 1.88 (95% CI, 1.33 to 2.65) and 1.66 (95%
CI, 1.14 to 2.41) for current and former smokers versus non-
smokers, respectively. BMI was associated with survival in
multivariate model. As BMI increased from underweight to obese,
there was a trend towards a reduction in the likelihood of death in
multivariate analysis (Ptrend=0.002). Compared with normal-
weight or underweight patients, the multivariate HR for survival
was 0.66 (95% CI, 0.48 to 0.90) and 0.47 (95% CI, 0.23 to 0.97)
for overweight and obese patients, respectively. When variable of
pack-years replaced smoking status The pretreatment light smoker
was found a 68% (95% CI, 15% to 146%) increase in the
likelihood of death and higher likelihood of death was 84% (95%
CI, 30% to 160%) for heavy smoker. The dosage effect of pack-
years on survival was significant in multivariate analysis
(Ptrend=0.003). Of the other lifestyle behaviors, alcohol intake
and frequency of fruit intake lost statistically significant associa-
tions with survival after adjustment for clinical variables and
demographic characteristics.
Discussion
A number of studies have reported that smoking is a predictor of
unfavorable survival among head and neck cancer. Most of these
studies have shown that smoking before treatment was associated
with a worse prognosis [1–3,10,11]. A few of the studies reported
that the survival of patients with head and neck cancer who
continued to smoke during therapy was lower than that of patients
who quit smoking [12–14]. Whether head and neck squamous cell
carcinoma are caused by smoking or not, pretreatment smoking
has been reported to influence those patients’ survival. However,
NPC is rare in most part of world, few or no cases of NPC were
included in the study populations in previous reports. To date,
whether or not smoking influences the survival of patients with
NPC is unknown. The large prospective study described here is
novel because the cohorts were limited to a specific disease, NPC,
with a unique etiology and unique patient characteristics. Our
findings provide evidence that pretreatment smoking is associated
with a worse prognosis in patients with NPC. The pretreatment
smoking status record may provide an easily available, practical,
and non-invasive supplement for predicting clinical outcomes.
This information would also offer clinicians guidance for early
intervention and follow-up more closely after treatment in heavy
smokers.
Heavy alcohol use might lead to nutritional deficiencies by
reducing the consumption of foods rich in micronutrients [15]. In
Table 2. Univariate hazard ratios from Cox proportional
hazards regression models.
Variable HR 95% CI P
Age ($v,46 years) 1.41 1.09 to 1.81 .009
Female 0.51 0.37 to 0.71 ,.0001
Clinical stage 1.86 1.58 to 2.20 ,.0001
Treatment (CRT v RT+CT) 0.47 0.35 to 0.63 ,.0001
Without spouse 1.21 0.69 to 2.12 .507
University or more 0.57 0.38 to 0.86 .008
Smoking status Ptrend,.0001
Never smoked 1.00 Ref.
Former smoker 2.06 1.49 to 2.85 ,.0001
Current smoker 2.14 1.57 to 2.90 ,.0001
Pack-years Ptrend,.0001
Never 1.00 Ref.
,25 Pack-years 1.85 1.34 to 2.54 ,.0001
$25 Pack-years 2.46 1.80 to 3.37 ,.0001
Alcohol intake Ptrend=.001
Nondrinker 1.00 Ref.
#1 drink per day on average 1.26 0.95 to 1.65 .104
.1 drink per day on average 2.22 1.41 to 3.50 .001
Duration of alcohol intake Ptrend=.009
Nondrinker 1.00 Ref.
,20 years 1.28 0.98 to 1.67 .070
$20 years 1.81 1.10 to 2.98 .019
Frequency of fruit intake Ptrend=.008
Less than monthly 1.00 Ref.
Monthly - weekly 0.77 0.56 to 1.05 .097
Daily or more 0.63 0.46 to 0.89 .007
BMI (kg/m
2) Ptrend=.002
Underweight (18.48 or less) 0.92 0.59 to 1.44 .724
Normal (18.50 to 22.99) 1.00 Ref.
Overweight (23.00 to 27.49) 0.62 0.46 to 0.85 .003
Obese (27.50 or more) 0.44 0.22 to 0.90 .025
Abbreviation: HR, Hazard Ratio; CRT, Concurrent chemoradiotherapy; RT+CT,
Radiotherapy+Chemotherapy.
doi:10.1371/journal.pone.0036515.t002
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[16]. thus favoring cancer development. The suppression of
natural killer cell activity in alcohol-exposed mice lends support to
this idea [17]. In this study, Pretreatment alcohol intake was
associated with poor survival in univariate analysis but was not a
predictor of survival in multivariate analysis. Our findings are
consistent with the role of alcohol reported in a study by Duffy et
al. These authors found that the relationship between drinking
problem and the survival of patients with head and neck cancer
was significant in univariate analysis but not in multivariate
analysis [3]. Similarly, Dikshit et al. observed that only high
consumption of alcohol ($121 g/day) had a marginally significant
influence on overall survival in laryngeal and hypopharyngeal
cancers (HR=1.3; 95% CI, 1.0 to 1.6) [2]. Farshadpour et al.
reported that only tobacco and alcohol used together can affect
overall survival in patients with head and neck squamous cell
carcinoma [18]. In several case-control studies, alcohol consump-
tion was not associated with NPC risk in Asian populations [19–
22]. Here, we present additional data describing the relationship
between pretreatment alcohol intake and outcome in nasopha-
ryngeal carcinoma survivors. The effects of continued alcohol use
after diagnosis or treatment on survival of NPC patient deserved
the collection of data to describe.
The pretreatment intake of fruit was significantly related to
longer survival time in NPC patients in univariate analysis. A
survival advantage associated with fruit consumption was also
identified among patients with head and neck squamous cell
carcinoma in univariate analysis [3]. Fruits are abundant sources
of anti-oxidants from multi-vitamins that may protect against
cancer [23]. Anti-oxidants counter the effects of reactive oxygen
species, compounds that initiate lipid peroxidation, leading to cell
damage, disruption of cell signaling, and increased viral replication
and expression, which are all pivotal events in carcinogenesis [24–
27]. A vegetable-rich diet may have a favorable effect on cancer
prognosis (e.g., breast cancer, colon cancer, epithelial ovarian
cancer, and oral cancer) [25,28–31]. In addition, we found that
pretreatment consumption of neither tea nor Cantonese herbal tea
influenced the survival of patients with NPC.
Increased body weight was associated with increased death rates
for most cancers [32]. But an association between low BMI at
diagnosis and poor prognosis has sometimes also been reported in
patients with lung cancer [32,33], head and neck cancer [34],
Figure 1. Kaplan-Meier plots of the influence of various lifestyle behaviors on survival in NPC patients. (A) Smoking status; (B) Lifetime
cigarette consumption; (C) Alcohol intake; (D) Duration of alcohol intake; (E) Frequency of fruit intake; (F) Body-mass index.
doi:10.1371/journal.pone.0036515.g001
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cancer [38]. There are several possible reasons underlying an
association between low weight and poor outcome in different
cancers. The further analysis was found that the NPC patients
with normal/low BMI were more likely to have an advanced stage
at diagnosis (Table S4). This was interesting that the consistent
finding was reported in esophageal cancer [39]. It helped us to
explain overweight/obese NPC patients obtained better survival
partially due to those with early stage. However, we have already
adjusted clinical staging in multivariate model, and the BMI
remained an independent prognostic factor. This results need to
be further investigated by other independent cohorts. Another
explanation we speculated was that a patient with a higher
pretreatment BMI might have more weight to lose and fall to
normal weight during treatment than would a patient of normal
weight. The pretreatment overweight and obese patients might
show strong resistance to malnutrition. In some cases, the
treatment of an NPC patient is interrupted often due to
malnutrition during radiotherapy [40]. As we know, interruptions
or prolonged treatment have an adverse effect on radiotherapy
outcomes in NPC patients [41]. Moreover, Fang et al found that
pretreatment nausea/vomiting and appetite loss were predictive of
poor overall survival after adjusting for age, sex, smoking, and
cancer stage in multivariate analysis [42]. It supported our finding
that decreased BMI was associated with poor survival in patients
with NPC. Unfortunately, for the budget limitation, we haven’t
obtained the information of weight lost during treatment. The
impact of change in weight during treatments could not be
assessed.
There are some limitations in our study. First, several studies
referred that the occurrence of lifestyle changes during lifetime
(before and after 50 years old) could influence on survival.
However, we haven’t collected the specific information and the
relevant results cannot be provided by this study. Second, lifestyle
sociologic public health variables common in western countries,
such as mental depression, have not been measured in the study.
Third, co-morbidity and quality of life (QoL) are two potential
prognostic predictors for patients with NPC. However, until now
no significant results have been reported in NPC patients that co-
morbidity influence on NPC patients’ survival [42–44]. In 2010,
Fang at el have reported that the pretreatment QoL provided
predictive value for prognosis of patients with NPC [42]. Our
questionnaire was not included the items of co-morbidity score
and QoL score. Without adjusting for these two covariates, an
explanation for any single lifestyle behavior effect on NPC
prognosis should be made carefully.
Recently, more and more prospective cohort studies have
provided important evidence of the effect of pretreatment health
behaviors on survival. However, as Gritz et al [45] commented,
most clinical trials fail to assess status after registration, or fail to
analyze these data even if they are collected, therefore, we are
missing major opportunities to detect the effects of the behaviors
on cancer survivor. To take smoking habit for example, we are still
lack of the knowledge of possible adverse effects of smoking and
benefits of cessation during the course of treatment and across
follow-up [46]. It might be of particular interest to study in
patients treated with chemotherapy, given that smoking status is
proving to affect differentially the response to some treatment
agents via molecular alterations and effects on drug metabolism
[47]. Interestingly, Duffy et al [3] have conducted a clinical trial in
Head and Neck Cancer, and participants were resurveyed every 3
months for 2 years and annually thereafter, we expect this study
could provide very useful information in clinical practice.
In conclusion, to our knowledge, this is the first large
prospective study investigating the roles of lifestyle behaviors as
predictors of survival for patients with NPC. Our results show that
pretreatment smoking and BMI influence the survival of patients
with NPC. Moreover, pretreatment alcohol consumption and fruit
intake have potential effect on prognosis of NPC survivors. Future
assessments as to whether changes in lifestyle behaviors after
diagnosis can improve the survival of NPC patients need to be
performed in a long-term follow-up study.
Materials and Methods
Patients
This was a prospective cohort study. Research assistants
approached 1,610 newly diagnosed patients with NPC who were
treated at the Sun Yat-sen University Cancer Center (SYSUCC)
between October 2005 and October 2007. The exclusion criteria
were as follows: age less than 18 years (n=8); pregnant (n=0); not
treated with radiotherapy (n=15); previous or synchronous
malignancies (n=1); no contact information for follow-up
(n=40); self-reported as non-Guangdong Chinese and residing
outside of Guangdong province (n=2); unable to understand
(n=1) or unwilling to complete (n=10) the questionnaire. There
were 1,533 patients recruited into the study. The pretreatment
evaluation included a physical examination, a chest x-ray,
magnetic resonance image scans of the head and neck, a bone
scan and an abdominal sonogram.
Table 3. Multivariate analyses of clinical variables,
demographics and lifestyle behaviors to predict survival.
Variables HR 95% CI P
Age ($v,46 years) 1.26 0.94 to 1.69 0.122
Without spouse 1.59 0.87 to 2.92 0.135
University or more 0.86 0.56 to 1.32 0.486
Clinical stage Ptrend,0.001
Stage I+II 1.00 Ref.
Stage III 2.47 1.60 to 3.81 ,0.001
Stage IV 3.11 2.02 to 4.78 ,0.001
Smoking status Ptrend,0.001
Never smoked 1.00 Ref.
Former smoker 1.66 1.14 to 2.41 0.008
Current smoker 1.88 1.33 to 2.65 ,0.001
Alcohol intake
#1 drink per day on average 1.00 Ref.
.1 drink per day on average 1.28 0.77 to 2.14 0.341
Frequency of fruit intake Ptrend=0.212
Less than monthly 1.00 Ref.
Monthly - weekly 0.84 0.60 to 1.20 0.341
Daily or more 0.78 0.53 to 1.14 0.203
BMI (kg/m
2) Ptrend=0.002
Underweight or normal 1.00 Ref.
Overweight 0.66 0.48 to 0.90 0.010
Obese 0.47 0.23 to 0.97 0.041
Note: Each HR is adjusted simultaneously for all the other variables in the table.
Abbreviation: HR, Hazard Ratio.
doi:10.1371/journal.pone.0036515.t003
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pants during face-to-face interviews. Data were collected for
demographic characteristics (such as age, gender, marital status,
education), lifestyle information (body mass index, cigarette
smoking, alcohol intake, dietary habits, tea consumption, and
Cantonese herbal tea consumption). After calculation of their
body-mass index, the patients were grouped into four BMI
classifications according to the WHO recommendations for Asian
populations [48]: less than 18.5 kg/m
2=underweight; 18.5–
22.99 kg/m
2=normal-weight; 23.0–27.49 kg/m
2=overweight
and 27.5 kg/m
2 or more=obese. The lifestyle questionnaire has
been described previously [49,50]. The smoking items design was
based on the Arizona Smoking Assessment Questionnaire [51].
Smoking information included age at initiation and cessation of
smoking and the number of cigarettes smoked per day in certain
phases of life. Former smokers were defined as smokers who had
quit smoking at least 1 year before presentation. Never smokers
were defined as those who had smoked fewer than 100 cigarettes
in their lifetime. To assess cumulative exposure, pack-years were
calculated as follows: the average number of cigarettes smoked per
day was divided by 20 and multiplied by the total number of years
of reported smoking. Alcohol consumption was measured by
reference to the Lifetime Drinking History [52] and Arizona Food
Frequency Questionnaire [51]. The consumption of alcohol was
recorded as the average amount of all alcoholic beverages (beer,
wine, and liquor) that participants consumed during each time
period in which their regular drinking were consistent. A medium
serving size (one drink) was defined as 12 ounces of beer, 5 ounces
of wine, or 1.5 ounces of liquor [53]. The dietary intake frequency
(including fruits and vegetables) was assessed by reference to the
Arizona Food Frequency Questionnaire. However, vegetables play
an important role at the Cantonese dining table. Most Cantonese
eat vegetables every day, at lunch, supper, and morning tea
(breakfast). In our vegetable data, ninety-nine percent of patients
selected the options of eating vegetables every day and at least one
dish per meal. Thus, an assessment of the association between
vegetable intake and the survival of patients with NPC could not
be performed. The Arizona Tea Questionnaire [51] was
referenced to estimate tea drinking and Cantonese herbal tea
consumption.
Clinical stages were classified using the American Joint
Committee on Cancer (AJCC) staging system published in 2002
[54]. The distribution of subjects by clinical stages was as follows:
stage I, 106 (6.9%); stage II, 350 (22.8%); stage III, 614 (40.1%);
and stage IV, 463 (30.2%). All patients were treated with definitive
radiation therapy. Of these, 1,305 patients (85.1%) received two-
dimensional conformal RT and 228 patients (14.9%) received
intensity-modulated RT. The technical details of the radiation
therapy have been described previously [55,56]. The prescribed
dose ranged from 68 to 78 Gy depending on the tumor stage, with
a daily fraction of 2.0 to 2.27 Gy and five fractions per week. More
than two-thirds of the patients received combination chemor-
adiotherapy because of their advanced stage; 637 patients (41.6%)
received concurrent chemotherapy, and 456 patients (29.7%)
received induction and/or adjuvant chemotherapy. The pre-
scribed concurrent chemotherapy regimen was 80 to 100 mg/m
2
of cisplatin every 3 weeks or 30 to 40 mg/m
2 of cisplatin every
week. The induction or adjuvant chemotherapy regimen was
fluorouracil plus cisplatin-based and was administered every 3
weeks.
Follow-up
After completion of therapy, the patients were observed
regularly until death or their last follow-up appointment. For
each subject, the start of the follow-up period was defined as the
date of diagnosis of nasopharyngeal carcinoma. The end of the
follow-up period was set to 31 October 2010. The patients were
observed at 3-month intervals during the first 3 years and at 6-
month intervals thereafter. For those patients who were lost to
follow-up, their survival information was obtained from Death
Registry in the Department of Public Security of guangdong
province. Patients lost to follow-up and not found on the Death
Registry File were censored at the last follow-up appointment. The
median follow-up duration was 40 months (range, 2.07 to 60.43
months).
Statistical analysis
Statistical analysis was performed using the Stata 10.0 statistical
software package (Stata Corp.; College Station, TX). Survival time
was calculated from the date of NPC diagnosis to the date of death
or last follow-up. Those patients who were alive at the last day of
follow-up were censored. Median follow-up time was computed
with censored observations only. Survival curves were estimated
by the Kaplan-Meier method. The log-rank test was used to
estimate the statistical differences between survival curves. Cox
proportional hazards analysis was performed to calculate the
hazard ratio (HR) and the 95% confidence interval (CI) to
evaluate the association between lifestyle behaviors and survival.
In addition, a multivariate Cox regression was performed to adjust
for other covariates. Each lifestyle behavior was considered
separately in the Cox proportional hazards regression model
because of the multicollinearity among these variables (Table S2
and S3). To assess collinearity in each lifestyle behavior variable,
Spearman’s correlation was calculated and the variance inflation
factor was estimated by multivariate regression [57–59]. A two-
tailed P value of 0.05 or less was considered statistically significant.
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